After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, FATE falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Fate Therapeutics Inc is $151.31M. A total of 1.42 million shares were traded on the day, compared to an average of 2.05M shares.
In the most recent transaction, Wolchko J Scott bought 113,178 shares of FATE for 0.93 per share on Mar 06 ’25. In a previous transaction on Jan 10 ’25, Bressi Jerome Charles sold 5,980 shares at 1.55 per share. FATE shares that the insider owns now total 270,203.
Among the insiders who sold shares, TAHL CINDY disposed of 5,654 shares on Jan 10 ’25 at a per-share price of $1.55. This resulted in the insider holding 336,707 shares of FATE after the transaction. In another insider transaction, Valamehr Bahram sold 8,705 shares at $1.54 per share on Jan 10 ’25. Company shares held by the President and CEO now total 349,364.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, FATE has a high of $5.92 and a low of $0.66.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. FATE’s latest balance sheet shows that the firm has $615.91M in Cash & Short Term Investments as of fiscal 2021. There were $114.82M in debt and $81.28M in liabilities at the time. Its Book Value Per Share was $2.52, while its Total Shareholder’s Equity was $678.84M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FATE is Buy with a score of 3.80.
